Infant Resuscitators Market Size, Share, and Industry Analysis, By Product Type (T-piece Resuscitator, Flow Inflating Resuscitator, and Self-inflating Resuscitator), By Usage (Reusable and Disposable ), By Indication (Apnea, Lung Disease, Birth Asphyxia, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2024-2032

Infant resuscitators refer to medical devices that are designed to provide respiratory support to newborns who require assistance for breathing at birth. These devices are crucial in ensuring the successful transition from in utero (in the womb or uterus) to an independent ex-utero state, particularly for preterm infants (babies born alive before 37 weeks of pregnancy are completed), who are more susceptible to respiratory distress due to immature lungs.

The growth of the infant resuscitators market is primarily attributed to the increasing prevalence of premature births. Premature babies are more susceptible to respiratory distress, hypoxia, and other complications that require a quick intervention. This has led to an increased demand for infant resuscitators in the management of premature birth complications.

In order to deal with such complications, healthcare providers are seeking advanced infant resuscitators that can provide adequate ventilation and oxygenation to premature babies. Moreover, infant resuscitators enable protection from lung injuries, establish and maintain functional residual capacity (FRC) during transition at birth, and promote normothermia in neonatal intensive care unit (NICU) admission. These factors and benefits are expected to boost the market growth during the forecast period.

• For instance, as per the article published by the International Journal of the Africa Nursing Sciences in 2023, an estimated 15 million babies are born preterm across the globe. This scenario leads to an improper development of the lungs of the babies, which is expected to boost the demand for infant resuscitators in the coming years.

Furthermore, the significant burden of asphyxia among newborns, which leads to severe and long-lasting effects on their health, is expected to necessitate the use of infant resuscitators to provide timely and effective respiratory support, thereby driving market growth in the coming years. Moreover, this high disease burden is leading to a growing awareness and education among healthcare professionals regarding the importance of timely and effective respiratory support in newborns. This increasing awareness is anticipated to boost the adoption rate of infant resuscitators, thereby driving market growth in the forthcoming years.

The COVID-19 pandemic positively impacted the market growth in 2020 due to the increased utilization of infant resuscitators during the COVID-19 pandemic. This high usage was mainly attributed to the increased awareness of respiratory health and the surge in the incidence of severe respiratory distress in neonates due to viral infections in 2020.

• For instance, according to the National Center for Biotechnology Information (NCBI) in April 2020, a study on neonatal resuscitation and post-resuscitation care of infants born to mothers with suspected or confirmed COVID-19 infection highlighted the need for a stepwise approach to resuscitation, stabilization, and postnatal care, considering the risks to both the neonate and healthcare providers. This boosted the demand for infant resuscitators, propelling the market growth in 2020.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries/Region, 2023


• Key Industry Developments (Mergers, Acquisitions, and Partnerships) By Key Players


• Number of Preterm Births, By Key Countries/Region, 2023


• Overview: Technological Advancements in Infant Resuscitators


• Impact of COVID-19 on the Market        

Analysis by Product Type

Based on product type, the market is segmented into T-piece resuscitator, flow Inflating resuscitator, and self-inflating resuscitator. The self-inflating resuscitator segment is projected to account for a significant share of the global infant resuscitators market during the forecast period. Self-inflating resuscitators are simple to use and do not require a compressed gas source, making them suitable for use in resource-limited settings or during transport. These benefits associated with the self-inflating resuscitators are expected to boost segmental growth in the upcoming years.

On the other hand, the T-piece resuscitator segment is projected to expand at a significant CAGR during the forecast timeframe. This is due to the fact that T-piece resuscitators are widely used in neonatal resuscitation and are recommended in international guidelines. They allow for precise control of peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP), making them a popular choice among healthcare professionals.

• For instance, as of June 2024, Fisher & Paykel Healthcare Limited stated that the international neonatal resuscitation guidelines recommend the use of a T-piece resuscitator over self-inflating resuscitators and flow inflating resuscitators to protect the newborn’s lungs. This is expected to boost the demand for T-piece resuscitators, thus driving the segment growth during the projection period.

Regional Analysis

To gain extensive insights into the market, Request for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the infant resuscitators market during the forecast period. The growth is primarily attributed to the advancements in the development of advanced infant resuscitators with additional features in the region. These advancements in technology enable infant resuscitators to be more effective and easier to use, leading to their increased adoption. Furthermore, the rising incidence of lung diseases such as bronchopulmonary dysplasia (BPD) among newborns is propelling the demand for infant resuscitators in the region. This is anticipated to boost market growth in the coming years.

• For instance, as of June 2024, the American Lung Association reports that an estimated 10,000 to 15,000 newborns develop bronchopulmonary dysplasia (BPD) in the U.S. annually.

Asia Pacific is projected to grow at a significant CAGR during the forecast timeframe. The increasing need for portable and easy-to-use devices in emergencies in the region is expected to drive the demand for portable infant resuscitators. This growing demand for portable devices is primarily due to the surging incidence of respiratory diseases, including influenza and Mycoplasma pneumonia, in the region. These conditions may require admission to the emergency department and oxygen therapy during patient transport, which is expected to increase the demand for infant resuscitators

• For instance, in November 2023, China’s National Health Commission reported that the growing incidence of respiratory diseases predominantly affected children in Northern China. This is anticipated to increase the adoption of portable infant resuscitators, thereby driving regional market growth during the forecast period.

Key Players Covered

The market consists of significant players, such as Flexicare (Group) Limited, Ambu A/S,  nice Neotech Medical Systems Pvt. Ltd., Mercury Medical, ICU Medical, Inc., Medtronic, VYAIRE MEDICAL, INC., Laerdal Medical, Besmed Health Business Corp., and AirLife.

Key Industry Developments

• In October 2022, Laerdal Medical announced that its number of silicone resuscitators and masks received the EU Medical Device Regulation (MDR) approval, enabling medical professionals to facilitate assisted ventilation of patients in pre-hospital, in-hospital, and post-hospital care. These products can also be used for infants.


• In January 2022, ICU Medical Inc. acquired Smiths Medical from Smiths Group plc, including its syringe and ambulatory infusion devices, vascular access, and vital care products, such as resuscitators.


• In August 2021, the University of Sydney and Westmead Hospital start-up raised USD 784,000 for a baby resuscitation system to resuscitate babies struggling to breathe after birth safely.